Gaps in Care Post Discharge for Mild Traumatic Brain Injury

Share this content:
Gaps in Care Post Discharge for Mild Traumatic Brain Injury
Gaps in Care Post Discharge for Mild Traumatic Brain Injury

TUESDAY, May 29, 2018 (HealthDay News) -- There are considerable gaps in follow-up care for patients with mild traumatic brain injury (mTBI) who have been discharged from the hospital, according to a study published online May 25 in JAMA Network Open.

Seth A. Seabury, Ph.D., from the University of Southern California in Los Angeles, and colleagues conducted a cohort study using data for patients with mTBI. The authors examined site-specific variations in follow-up care and characteristics associated with receipt of follow-up care. Data were included for 831 patients who completed follow-up surveys at two weeks and three months after injury.

The researchers found that fewer than half of the patients reported receiving TBI educational materials at discharge or seeing a physician or other health care practitioner within three months after injury (42 and 44 percent, respectively). Across sites, there was variation in follow-up care, with provision of educational materials varying from 19 to 72 percent after adjustment for patient characteristics. Thirty-nine percent of the 236 patients with a positive finding on computed tomography (CT) scan had not seen a medical practitioner three months after the injury. Only 52 percent of the 279 patients with three or more moderate-to-severe post-concussive symptoms reported having seen a medical practitioner by three months.

"There are gaps in follow-up care for patients with mTBI after hospital discharge, even those with a positive finding on CT or who continue to experience post-concussive symptoms," the authors write.

Several authors disclosed financial ties to the pharmaceutical, medical device, and other industries.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »